Boron neutron capture therapy for malignant gliomas

@article{Diaz2000BoronNC,
  title={Boron neutron capture therapy for malignant gliomas},
  author={Aidnag Z. Diaz and Jeffrey A. Coderre and Arjun D. Chanana and Ruimei Ma},
  journal={Annals of Medicine},
  year={2000},
  volume={32},
  pages={81 - 85}
}
Boron neutron capture therapy (BNCT) represents a promising modality for a relatively selective radiation dose delivery to the tumour tissue. Boron-10 nuclei capture slow ‘thermal’ neutrons preferentially and, upon capture, promptly undergo 10B(n,α)7Li reaction. The ionization tracks of energetic and heavy lithium and helium ions resulting from this reaction are only about one cell diameter in length (∼ 14 μm). Because of their high linear energy transfer (LET) these ions have a high relative… 

Solutions for clinical implementation of boron neutron capture therapy in Finland

TLDR
The objective of this work was to develop the dosimetry methods of the FiR 1 BNCT beam, estimate the blood boron level after a bor onophenylalanine fructose (BPA-F) infusion and implement a system for patient positioning in the Finnish BnCT facility.

Boron neutron capture therapy using reactor epithermal neutron beams could effectively control in‐transit and lymph node metastases originating from a cutaneous malignant melanoma

Dear Editor, Boron neutron capture therapy (BNCT) using boronophenylalanine (BPA) is a selective radiotherapeutic approach for cancer cells and has achieved good results for treating malignant

Semiconductor dosimetry of epithermal neutron beams for Boron neutron capture therapy

Boron neutron capture therapy (BNCT) is a binary targeted therapy that uses suitably designed pharmaceuticals to deliver 10 B to tumor cells. The region is then irradiated with neutrons and neutron

Boron-Containing Bioactive Molecules: An Approach to Boron Neutron Capture Therapy

Boron Neutron Capture Therapy (BNCT) is a binary therapeutic modality for cancer treatment that involves the irradiation of B-localized tumours with low-energy neutrons, which results in the

Clinical Viability of Boron Neutron Capture Therapy for Personalized Radiation Treatment

TLDR
This work provides an overview of the fundamental principles, recent advances, and future directions of BNCT as cell-targeted cancer therapy for personalized radiation treatment.

Ligand Liposomes and Boron Neutron Capture Therapy

TLDR
Boron neutron capture therapy (BNCT) has been used both experimentally and clinically for the treatment of gliomas and melanomas, with varying results, but it is uncertain whether enough boron is taken up by micro-invasive tumor cells.

Boron Neutron Capture Therapy for Glioblastoma Multiforme: Clinical Studies in Sweden

TLDR
A boron neutron capture therapy (BNCT) facility has been constructed at Studsvik, Sweden and, presently, a protocol for BNCT treatment of glioblastoma patients who have not received any therapy other than surgery is involved.

Ligand liposomes and boron neutron capture therapy

TLDR
Boron neutron capture therapy (BNCT) has been used both experimentally and clinically for the treatment of gliomas and melanomas, with varying results, but it is uncertain whether enough boron is taken up by micro-invasive tumor cells.

Boron neutron capture therapy for glioblastoma multiforme: clinical studies in Sweden

TLDR
A boron neutron capture therapy (BNCT) facility has been constructed at Studsvik, Sweden and, presently, a protocol for BNCT treatment of glioblastoma patients who have not received any therapy other than surgery is involved.

Boron neutron capture therapy (BNCT) for glioblastoma multiforme: a phase II study evaluating a prolonged high-dose of boronophenylalanine (BPA).

...

References

SHOWING 1-10 OF 28 REFERENCES

A history of boron neutron capture therapy of brain tumours. Postulation of a brain radiation dose tolerance limit.

  • D. Slatkin
  • Physics, Medicine
    Brain : a journal of neurology
  • 1991
TLDR
A new dosimetric analysis of the 1959-1961 clinical trials of BNCT at Brookhaven National Laboratory yields an acute radiation dose tolerance limit estimate of approximately 10 Gy-Eq to the capillary endothelium of human basal ganglia from BnCT.

Boron neutron capture therapy (BNCT) for high-grade gliomas of the brain: a cautionary note.

Brain Tolerance in Dogs to Boron Neutron Capture Therapy with Borocaptate Sodium (BSH) or Boronophenylalanine (BPA)

Research programs investigating the potential use of BNCT for brain tumors have been initiated in Europe and in the U.S. using epithermal neutron beams and either borocaptate sodium (BSH) or

Evaluation of carborane-containing porphyrins as tumour targeting agents for boron neutron capture therapy.

A number of carborane-containing porphyrins were administered to mice bearing subcutaneously transplanted mammary carcinomas. Administration was via serial intraperitoneal (i.p.) injections to assess

Installation and testing of an optimized epithermal neutron beam at the Brookhaven Medical Research Reactor (BMRR).

TLDR
A perusal of data on parameters obtained in NCT indicates that the TG would increase significantly beyond values projected in this paper if the absolute amount of 10B could be increased above 30 ppm.

The Monte Carlo Simulation of the Biological Effect of the 10B(n,α)7Li Reaction in Cells and Tissue and Its Implication for Boron Neutron Capture Therapy

TLDR
The results here show that high-level exposure to high-LET particles (resulting in cell killing) should be treated in an analogous manner, and the choice of boron carries in neutron capture therapy is considered.

Clinical results of long-surviving brain tumor patients who underwent boron neutron capture therapy.

Central nervous system radiation syndrome in mice from preferential 10B(n, alpha)7Li irradiation of brain vasculature.

TLDR
Results are compatible with morphologic evidence that endothelial cell damage is a major determinant of acute lethality from the CNS radiation syndrome and it was observed that boric acid is a low linear energy transfer radiation-enhancement agent in vivo.

Long‐term follow‐up for brain metastases treated by percutaneous stereotactic single high‐dose irradiation

Surgery is considered the treatment of choice for solitary brain lesions, and radiation therapy is indicated for metastases only in vital or sensitive regions that cannot be excised without risk of

Selective boron delivery to murine tumors by lipophilic species incorporated in the membranes of unilamellar liposomes.

TLDR
The incorporation of both the nido-carborane species K[nido-7-CH3(CH2)15-7,8-C2B9H11] and the hydrophilic species, Na3[1-(2'-B10H9)-2-NH3B 10H8], within the same liposomes demonstrated significantly enhanced biodistribution characteristics.